| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.7 |